Hemophilia Treatment Market – Growth, Future Prospects, and Competitive Analysis, 2017 – 2025, the global hemophilia treatment market was valued at US$ 10,042.7 Mn in 2016, and is expected to reach US$ 15,124.7 Mn by 2025, expanding at a CAGR of 4.5% from 2017 to 2025.
Browse Full Report Visit :- http://www.acutemarketreports.com/report/hemophilia-treatment-market
According to a study by the National Hemophilia Foundation (U.S.), around 0.4million people across the world suffer from hemophilia. Out of the total prevalent population of hemophilia, approximately only 25% receives proper treatment. The World Federation of Hemophilia is striving to bridge this gap through educating patients and general population and conducting various programs. Lack of awareness about bleeding disorders and limited access to treatment have so far hindered the growth of hemophilia treatment market. However, rise in funding for research and development, increasing healthcare expenditure, advancement in diagnostic technology would propel the growth of hemophilia treatment market. The World Federation of Hemophilia and WHO both recommend prophylaxis as the optimal therapy for hemophilia. Across North America, Europe and Japan, prophylactic therapies are being widely used. Furthermore, increase in demand on prophylactic treatment and with availability of recombinant factor provides immense growth opportunities of hemophilia market.
Market Competition Assessment:
Key players in the global hemophilia market are Baxter International, Inc., Baxalta, Bayer AG, Biogen Idec, Inc., Chugai Pharmaceutical Co., CSL Behring, Genentech, Inc., Hospira, Inc., Ferring B.V., Kedrion, Octapharma AG, Novo Nordisk, Pfizer, Inc., Sanofi SA, Swedish Orphan Biovitrum AB, Shire Plc. and others.
Key Market Movements:
• Rising prevalence of hemophilia, with estimate of about 400,000 individuals affected by the disease. Around 75% of people do not receive required treatment for hemophilia.
• Rising awareness about hemophilia and other bleeding disorders among people due to various programs conducted by international and national bodies and pharmaceutical companies. Development of novel treatment options and educational program to holistically address the unmet need of the patients and care givers.
Download Free Sample Request :- http://www.acutemarketreports.com/request-free-sample/108109
Chapter 1. Preface
1.1. Report Scope and Description
1.2. Research Methodology
1.2.1. Phase I-Secondary Research
1.2.2. Phase II-Primary Research
1.2.3. Phase II-Expert Panel Review
1.2.5. Approach Adopted
Chapter 2. Executive Summary
2.1. Global Hemophilia Treatment Market Portraiture
2.1.1. Global Hemophilia Treatment Market, by Product Type, 2016
2.1.2. Global Hemophilia Treatment Market, by Hemophilia Type, 2016
2.1.3. Global Hemophilia Treatment Market, by Geography, 2016
Chapter 3. Hemophilia Treatment: Market Dynamics and Future Outlook
3.1. Market Overview
3.4.1. Attractive Investment Proposition, by Geography
3.5. Competitive Landscape
3.5.1. Competitive Landscape, by Key Players, 2016
To Get Complete Report @ http://www.acutemarketreports.com/report/hemophilia-treatment-market
Acute Market Reports is the most sufficient collection of market intelligence services online. It is your only source that can fulfill all your market research requirements.We provide online reports from over 100 best publishers and upgrade our collection regularly to offer you direct online access to the worlds most comprehensive and recent database with expert perceptions on worldwide industries, products, establishments and trends.
Our team consists of highly motivated market research professionals and they are accountable for creating the groundbreaking technology that we utilize in our search engine operations to easily recognize the most current market research reports online.
Contact Us :
Name : Chris Paul
ACUTE MARKET REPORTS
Designation : Global Sales Manager
Toll Free(US/CANADA): +1-855-455-8662
Email : firstname.lastname@example.org
Website : http://www.acutemarketreports.com